NCT04577248招募中不适用
The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Deutsches Herzzentrum Muenchen1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2020年9月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- Long-term mortality
研究概览
简要总结
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
详细描述
Long-term mortality after transcatheter mitral or tricuspid valve therapy
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 110 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age above 18 years and consentable
- •Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
- •Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
- •Written informed consent
排除标准
- •Patient's inability to fully cooperate with the protocol
结局指标
主要结局
Long-term mortality
时间窗: 5 years
Long-term mortality
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)Thrombotic Thrombocytopenic PurpuraNCT05389007Johannes Gutenberg University Mainz156
终止
不适用
A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft RecipientsRenal Transplant Recipients With Anti-HLA AntibodiesNCT02115503Databean52
招募中
不适用
Anthropometric Evaluation of a New Asian Specific Knee Prosthesis - The Genesis II SlimACTRN12611000289910Smith & Nephew1,060
Unknown
不适用
Prospective Observational Study Assessing Treatment and Outcomes of Patients With PrediabetesPrediabetesNCT01869101Tethys Bioscience, Inc.560
招募中
不适用
Real World Evidence of Fedratinib Effectiveness in MFPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPrimary MyelofibrosisNCT05883904Gruppo Italiano Malattie EMatologiche dell'Adulto93
